PRO.MED.CS Praha a.s. is a leading Czech independent pharmaceutical company with its own scientific-research base for the development of human drugs. PRO.MED.CS specialises in the production of tablets and coated tablets and capsules, whose daily production exceeds 1.5 million units. Portfolio covers mainly gastrointestinal, cardiovascular and musculoskeletal areas. PRO.MED.CS exports its products to more than 30 countries of Central and Eastern Europe and Central Asia. In recent years it is also asserting its position on West European markets. Company main goal is to bring onto the market proven, effective and safe products for a fair price.
| Website | http://www.promedcs.com |
| Revenue | $64.1 million |
| Employees | 416 (309 on RocketReach) |
| Founded | 1989 |
| Industry | Pharmaceutical Manufacturing |
| Web Rank | 36 Million |
| Keywords | Pharmaceutical Manufacturing, Drug Development, Tablet Production, Capsule Production, Drug Manufacturing, Pharmaceutical Research, Drug Formulation, Pharmaceutical Science, Drug Production, Scientific Research, Oral Medications, Dosage Forms, Clinical Trials, Healthcare |
| Competitors | Roche, Bayer, Philips, Boston Scientific, Stryker, Johnson & Johnson, GE HealthCare, Siemens Healthineers, Medtronic, Abbott +40 more (view full list) |
| NAICS | NAICS Code 621 Companies, NAICS Code 6216 Companies, NAICS Code 62161 Companies, NAICS Code 62 Companies |
Looking for a particular PRO.MED.CS employee's phone or email?
The PRO.MED.CS annual revenue was $64.1 million in 2026.
Alena Patrovska is the Chief People Officer of PRO.MED.CS.
309 people are employed at PRO.MED.CS.
The NAICS codes for PRO.MED.CS are [621, 6216, 62161, 62].